AI 멀티 호라이즌 분석
1-minute timeframe prints price below all EMAs/SMAs, RSI 40.76, MACD negative, volume below average, near lower Bollinger band; momentum weak.
15-minute and 1-hour timeframes show oversold RSI but still below short-term moving averages; 1H price below lower Bollinger, MACD negative; elevated volume but no bullish follow-through.
Daily, weekly and monthly frames show strong secular uptrend but extreme overbought RSI on weekly (100) and monthly (89); revenue growth accelerating and balance-sheet liquidity strong, yet FCF down 57% sequentially, net margin collapsed, insider net selling $15.6M.
Multi-horizon assessment shows mixed signals: revenue and balance sheet strength improved but profitability, FCF and insider flows are negative; technicals show extreme long-term overbought conditions and short-term bearish momentum. Overall bearish bias dominates.
상세 AI 펀더멘털 분석
We need answer with exact headings. Need ground data. Need analyze. Need note price odd: current price 221.07 but intraday 1m close 286.25 etc. Active timeframe 1D current_price=221.07. Session high 329.88 low 70.685. Need not resolve? Mention discrepancy? Need be careful.
Need produce comprehensive fundamental briefing. Need use provided financials. Need understand periods: Q1 FY2027? Dates: 2026-05-02 latest 10-Q, 2026-01-31 10-K (Q4 FY2026? annual), 2025-11-01 10-Q Q3 FY2026, 2025-08-02 10-Q Q2 FY2026. Income statement periods: Revenue 2026-05-02 = 2,417.8m; 2026-01-31 = 8,194.6m (annual, not quarter!) Titled last 4 periods but 2026-01-31 is 10-K annual, so revenue figures not comparable. Same with Net Income includes one-time? Need call out annual vs quarterly. The prompt says last 4 reporting periods? It says income statement last 4 periods, but 2026-01-31 is 10-K annual, while 2025-11-01 is quarter, 2025-08-02 quarter, 2026-05-02 quarter. Need be aware. 2026-01-31 revenue 8.19B is full fiscal year FY2026, not Q4. Need mention mixing annual with quarterly in data, so compute deltas only quarterly comparable quarters excluding annual? Need trend: Revenue latest Q (2026-05-02) $2,417.8m vs prior Q (2025-11-01) $2,074.5m = +16.5%; vs two quarters ago (2025-08-02) $2,006.1m +20.5%. The 2026-01-31 10-K revenue likely annual (fiscal year ending Jan 31, 2026) includes those quarters? Need not compare directly. Gross margins: 52.15%, 51.02% annual maybe, 51.57%, 50.38%. Latest vs prior comparable +0.58pp vs 2025-11, +1.77pp vs 2025-08. Operating margin latest 14.04% vs 17.25% prior comparable; 14.46% two quarters ago. Net income latest $34.5m vs $1,901.3m prior quarter, and $194.8m two quarters ago. But prior quarter includes large one-time gain? Need examine: 2025-11-01 net income $1,901.3m on revenue $2,074.5m net margin 91.65% implies probably one-time tax benefit or gain. Need not hallucinate. Need note. 2026-01-31 10-K net income $2,670.1m with revenue $8.19B net margin 32.58%. Need call out irregularities.
Balance sheet: Latest total assets 26,944.5m vs 20,586.3m 4 periods ago +30.9%; total liabilities 8,728.7 vs 7,164.6 +21.8%; equity 18,215.8 vs 13,421.7 +35.7%. Cash 3,843.6 vs 1,224.4 +213.9%. Long-term debt 4,961.3 vs 3,967.9 +25%. Inventory 1,400.9 vs 1,051.6 +33.2%. Current ratio improved 1.88 to 3.28. Working capital 2,113.6 to 5,187.2. Debt/equity 0.30 to 0.27. Retained earnings went from -840m to 1,336.5m, but latest 1,336.5 vs prior 1,355.8 slight decline. Need mention.
Cash flow: Need reconcile: Cash from Operations latest 638.8m; prior comparable 1,376.8m (2025-11-01) and 794.5m (2025-08-02). 2026-01-31 annual 1,750.5m. FCF latest 483.1m; prior quarter 1,137.0m; two quarters ago 628.2m. So latest FCF lower sequentially Q/Q but higher than two quarters ago? Actually latest 483.1 vs 794.5? Need compute FCF: 638.8 - 155.7 = 483.1; previous 1,376.8 - 239.8 = 1,137.0; 794.5 - 166.3 = 628.2. So decrease -57.5% vs prior quarter; -23.1% vs 2Q ago. Investing latest -1,421.4 vs prior +2,219.9; financing +1,987.4 vs -1,830.5. Significant.
Need insider activity: Sentiment neutral -10, buys $0 across 22 transactions, sells $15.6m across 37 transactions. Transactions show vesting/exercise at $0 plus sell-to-cover. Need parse: Multiple "Buy total $0" likely stock option exercises or RSU vest. Sells at $206.26, $199.24, $209.52, $180.50. Need mention no open-market buys with cash; all insider sales are likely routine sell-to-cover or vesting disposals. Net selling $15.6m. Need note 37 sells vs 22 buys but buys $0. For sentiment neutral.
Need multi-timeframe technical context: Need include relevant indicators. Need analyze across horizons.
Need price discrepancy: Current price 221.07 from 1D timeframe close, session high 329.88, low 70.685. Intraday 1m current 286.25, 15m close 286.61, 1H close 286.61. Active timeframe 1D current price 221.07. Wait 1D 200 bars open=83.875 -> close=221.07 (+163.57%) high=329.88 low=70.685. The 1D close 221.07, but 1m/15m/1H close around 286.6. This is inconsistent. Maybe because 1D timeframe last bar? The current price maybe after a gap? Need note data discrepancies. Market status regular. Need not assume "current" from intraday? We have current_price=221.07 in header, but 1D close=221.07. Wait 1D close=221.07, current_price=221.07. But 1m close=286.25, 15m close=286.61, 1H close=286.61. Maybe "1D" bar is previous daily close? The session high 329.88 low 70.685 suggests huge range over 200 sessions. 1m high/low 295.98/284.57 is current session. Hmm. Active timeframe 1D current price 221.07 maybe at time? But intraday current price should be 286.25? Need mention "as provided, top-line current price is 221.07 while active intraday timeframes print ~286.25–286.61; treat intraday levels with caution." Need maybe not dwell too much. Need use both.
Need ultra-short (minutes): 1m RSI 40.76, below 50; MACD negative -0.3484 below signal -0.1079; price below all EMAs (12,26,50) and SMA20/50/200; Bollinger lower 285.07, middle 287.94, upper 290.82; price 286.25 is near lower band. ATR 1.1155. Volume 70,189 vs SMA20 95,616, below average. So near-term momentum weak, short-term bias down within range. Need mention.
Short (hours-days): 15m RSI 34.41, 21 RSI 27.82 oversold-ish; MACD -3.62 and signal -3.24 bearish; price below EMA12 291.08, EMA26 294.7, EMA50 297.6, SMA20 293.01, SMA50 300.46, but above SMA200 290.61? Wait price 286.61 below SMA200 290.61. Need mention below most moving averages but some support near 285.29 lower band. 1H RSI 32.92; MACD +0.1418 vs signal +3.0742? Actually MACD line above signal? 0.14 > 3.07? no below, histogram negative; MACD below signal. Price 286.61 below SMA20 301.68, above SMA50 290.55? price 286.61 below 290.55, below SMA200 274.98? Actually SMA200 274.98, price above. So mixed. ATR 7.43. Volume on 1H 4.2m vs 3.4m average, elevated. Bollinger lower 287.64, price below lower band? price 286.61 < 287.64, below lower band, may be stretched. Need mention.
Long (weeks-months): 1D RSI 54.2, 21 49.65, neutral. MACD -3.89 above signal -8.78? Actually -3.89 > -8.78, histogram positive? MACD below zero but above signal, bullish crossover? Need mention MACD slowly recovering above signal. Price 221.07 above SMA20 199.35, below SMA50 241.14, above SMA200 140.11. Bollinger middle 199.35, upper 231.02, lower 167.67; price 221.07 above upper? No upper 231, middle 199, so upper half. Weekly RSI 100/97.8 extremely overbought, MACD strongly positive. Monthly RSI 88.97/77.64 overbought, MACD strong. Since long-term trend extremely strong (200-bar gain 163.57% on daily; weekly +403.87%, monthly +1111%). Need "the data appear to include an enormous run-up; long-term momentum is extreme, but RSI is stretched."
Need Key Levels & Triggers: Need derive from timeframes. For current session: 1D Bollinger 231.02 upper, 199.35 middle, 167.67 lower; SMAs 241.14, 213.94, 212.17, 208.28? Actually EMA 12=208.28, 26=212.17, 50=213.94, SMA20=199.35, SMA50=241.14, SMA200=140.11. For intraday: 1m support at 284.57/285.07, resistance 287.94-290.82; 15m support 285.29, resistance 293.01-300.72; 1H support 287.64, SMA200 274.98, resistance 301.68/315.72/339.6. Need mention current price 221.07 if using daily close vs intraday current 286.25. Need present levels with caveat. Key triggers: 1D close relative to 50-day SMA 241.14, 20-day 199.35; daily MACD crossing zero? Need mention.
Need Bull / Bear cases short-term and long-term. Need grounded. Need not include external. Need mention data limitations.
Need "Financial Health" interpretation latest period in light of trend.
Need maybe "Business Snapshot" basic: Marvell Technology, semiconductor company? Need from provided metadata: sector/industry not available. Need avoid hallucinating. But can say "Common stock of Marvell Technology, listed 2000, NASDAQ; no sector/industry provided." Need maybe known? We shouldn't rely? It's common knowledge? Need use provided. Could say "Fabless semiconductor?" (we know Marvell). But constraints "ground every claim in provided data" no external. We can mention "No sector/industry provided; business description not in payload." But user likely expects business snapshot. We can infer from financials? Need "Data set does not include a business description; the company is matched to Marvell Technology, Inc. (CIK 1835632), common stock. Revenue/margins/inventory indicate a design/manufacturing operation, but no product line data is supplied." Better.
Need "Financial Trends" 4-period trajectory: Need carefully label annual period. Let's construct.
Data periods:
- 2026-05-02 (Q? likely Q1 FY2027)
- 2026-01-31 (FY10-K, annual FY2026)
- 2025-11-01 (Q3 FY2026)
- 2025-08-02 (Q2 FY2026)
Could compute deltas: Revenue: 2025-08-02 2,006.1 -> 2025-11-01 2,074.5 (sequential +3.4%) -> annual 10-K 8,194.6 -> 2026-05-02 2,417.8. If compare latest vs 2025-11-01 +16.6%; latest vs 2025-08-02 +20.5%. Need mention annual 2026-01-31 is not a quarter; cannot compare to quarterly. Gross profit: latest 1,260.8 vs 1,069.8 prior quarter +17.9%; vs 1,010.6 two quarters ago +24.8%. Gross margin: 52.15% vs 51.57% vs 50.38%; expanding by 1.77pp over four periods. Operating income: 339.4 vs 357.8; slight -5.1% Q/Q, vs 290.1 +17.0% two quarters ago. But operating expense latest 921.4 vs 712.0/720.5; OpEx up +29.4% vs prior quarter. So operating margin 14.04% down from 17.25%, and below 14.46% two quarters ago. Net income: latest 34.5 vs prior quarter 1,901.3, vs 194.8. Net margin crashed from 91.65% to 1.43%; but prior quarter net margin 91.65% likely distorted by non-operating items/tax benefit. Need note "one-time/non-operating effects likely; don't extrapolate." EPS basic 0.04 vs 2.22 vs 0.23.
Balance sheet trajectory: Assets grew $4.9B or +23% from 2025-08-02? Actually total assets 26,944.5 vs 20,586.3 = +6,358.2 / 20,586.3 = 30.9%; vs prior 2026-01-31 22,285.3 = +4,659.2 / 22,285.3 = +20.9%. Equity grew from 13,421.7 to 18,215.8 = +4,794.1 / 13,421.7 = +35.7%; vs prior 14,308.4 = +3,907.4 / 14,308.4 = +27.3%. Cash 3,843.6 vs 1,224.4 = +219.1%; vs prior 2,638.8 = +45.7%. Long-term debt 4,961.3 vs 3,967.9 = +25.0%; vs prior 3,970.8 = +24.9%. So balance sheet expansion with more cash and debt; equity grew even more, debt/equity improved. Current ratio improved from 1.88 to 3.28 because current assets increased faster than current liabilities; current liabilities decreased from 3,220.5 to 2,276.8. Inventory rose from 1,051.6 to 1,400.9 (+33.2%), could be build for growth but watch. Retained earnings went from -840.0m to 1,010.5m to 1,355.8m to 1,336.5m; latest slight decline -19.3m after a large jump due to net income? Need mention.
Cash flow: CFO latest 638.8 vs prior quarter 1,376.8 (down -53.6%); vs 2025-08-02 794.5 (down -19.6%). Capex latest 155.7 vs prior 239.8; FCF 483.1 vs 1,137.0 (down -57.5%), vs 628.2 (down -23.1%). But annual CFO 1,750.5 for FY2026. FCF annual 1,396.4 vs latest quarter 483.1. Investing latest -1,421.4 vs prior +2,219.9; financing +1,987.4 vs -1,830.5. Need mention investing may include securities purchases/sales? Not enough.
Need "Financial Health": latest period has strong revenue growth, gross margin expansion, but profitability declined on OpEx and non-operating factors. Balance sheet stronger: cash $3.84B, current ratio 3.28, working capital $5.19B, debt/equity 0.27. FCF still positive $483.1m but down sequentially. Inventory up. Need mention no industry benchmark.
…
